Showing 1321-1330 of 3525 results for "".
State Legislation of EHRs: A Sweeping Precedent?
https://practicaldermatology.com/topics/practice-management/state-ehr-legislation-a-new-precedent/21483/A new law in Massachusetts requires all licensed physicians to be using an EHR by 2015.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21848/GLP-1 Receptor Agonists and the Aesthetic Patient: Considerations for the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-and-the-aesthetic-patient/48900/The impact of glucagon-like peptide-1 agonists (GLP-1), such as semaglutide, tirzepatide and liraglutide, has transformed the healthcare industry and, in particular, aesthetic dermatology. The most common intended use of these medications, namely diabetes management and weight loss, can lead to a muReflections On a Year Unlike Any Other
https://practicaldermatology.com/topics/practice-management/reflections-on-a-year-unlike-any-other/23398/Change is good and other hard lessons from 2020.Physician Spotlight
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight/20685/Practicing picture-perfect dermatology.New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21558/New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21688/Evaluating Hyaluronic Acids in Patients with Skin of Color
https://practicaldermatology.com/topics/general-topics/1109_05-php/22057/One expert places new findings in perspective and explains why new data on fillers in skin of color are essential.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20454/Loyal to Whose Fault?
https://practicaldermatology.com/topics/practice-management/loyal-to-whose-fault/23584/